| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Obstetrics and Gynecology University of Maryland School of Medicine Baltimore, Maryland 21201;
Anatomy University of Maryland School of Medicine Baltimore, Maryland 21201;
the Department of Physiology, Eastern Virginia Medical School Norfolk, Virginia 23501
Address all correspondence and requests for reprints to: Eugene D.Albrecht, Ph.D., Department of Obstetrics and Gynecology, Universityof Maryland School of Medicine, Bressler Research Laboratories 11-015, 655 West Baltimore Street, Baltimore, Maryland 21201.
Abstract
In the present study, a culture system of human placental cells was established to examine the role of estrogen and androgen in progesterone (P4) formation. Normal human placentae were obtained at term, and cells were dispersed in Hank's Balanced Salt Solution (5 ml/g tissue) containing 0.1% collagenase, 0.1% hyaluronidase, 0.01% deoxyribonuclease, and 1% fetal bovine serum for 2 h at 37 C. Dispersed placental cells (108 cells/ml) were placed in medium 199 with modified Earle's salts (pH 7.4) containing 10% fetal bovine serum, 12.5 mM HEPES buffer, 26 mM NaHCO3, and 40 µg/ml Gentamycin-SO4 and incubated for 72 h at 37 C and 5% CO2 in air to allow cell attachment. Medium was then changed (time zero), and P4 formation was studied thereafter.
Culture of placental cells for 96 h resulted in linear increases in P4 and estradiol (E2) formation, indicating the maintenance of cell viability and steroidogenic function. Mean ± SE P4 formation at 48 h was 246 ± 16 pg/µg DNA. To assess the role of estrogen on P4 formation, placental cells were incubated for a period of 48 h with various amounts (10-7-10-4 M) of the antiestrogen ethamoxytriphetol (MER-25), the aromatase inhibitor 4- hydroxyandrostenedione (4-OHA), and/or E2. Both MER-25 and 4-OHA resulted in a dose-dependent decline (P < 0.01) in P4 formation (80% decline at 10-4 M MER-25 or 4-OHA). The marked reduction in P4 formation caused by 4-OHA alone was reversed by concomitant addition of E2 however, E2 alone had no effect. To assess the role of androgens on P4 formation, cells were incubated for 48 h with increasing amounts (10-7-10-4 M) of androstenedione, dehydroepiandrosterone (DHA), or dihydrotestosterone. Although the formation of E2 was enhanced by DHA, formation of P4 was not affected by the aromatizable androgens DHA or androstenedione or the nonaromatizable dihydrotestosterone.
The decline in P4 formation by human placental cells in culture elicited by MER-25 or 4-OHA supports the hypothesis of a regulatory role for estrogen in placental P4 formation during human pregnancy. The lack of effect of exogenous estrogen suggests that the action of estrogen on P4 formation may be permissive. (Endocrinology 119: 998-1003, 1986)
Footnotes
* This work was supported by NIH Research Grant HD-13294.
Received December 21, 1985.
This article has been cited by other articles:
![]() |
N. Callejas, M Casado, L Bosca, and P Martin-Sanz Requirement of nuclear factor kappaB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts J. Cell Sci., January 9, 1999; 112(18): 3147 - 3155. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |